Trial Profile
Vaginal Progesterone for the Prevention of Preterm Birth in Twins: A Pilot Randomised, Factorial Designed Trial (POPPET)
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 01 Feb 2021
Price :
$35
*
At a glance
- Drugs Progesterone (Primary)
- Indications Preterm birth
- Focus Therapeutic Use
- Acronyms POPPET
- 26 Jan 2021 Status changed from not yet recruiting to withdrawn prior to enrolment as the trial fail to sort out the logistics of study drugs due to funding problems
- 31 Dec 2019 Planned End Date changed from 1 Dec 2021 to 1 Dec 2022.
- 31 Dec 2019 Planned primary completion date changed from 1 Apr 2021 to 1 Apr 2022.